BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230614T100000
DTEND;TZID=Europe/London:20230614T110000
DTSTAMP:20260407T222843
CREATED:20230517T102136Z
LAST-MODIFIED:20230614T104607Z
UID:23626-1686736800-1686740400@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Validating Digital Health: From Artificial Intelligence to Clinical Evidence
DESCRIPTION:We are delighted to be holding our next Clinical Trials Special Interest Group series\, organised in partnership with Afortiori Development. This online event will bring together a panel of experts to answer your questions relating to Validating Digital Health: From Artificial Intelligence to Clinical Evidence. \nRather than formal presentations\, this hour-long session will take a roundtable discussion / Q&A format. \nOur panel brings together specialists from our partners at Afortiori\, alongside guest speakers from other industry leaders. \nJoining us on the day will be: \n\nDr Nicola Wall\, Afortiori Development\nProf Peter Bannister – Entrepreneur and Expert technology specialist\nDr Lauris Kemp – IP Expert\nTimothy Bubb – Regulatory Expert\n\nFull speaker biographies can be found below. \nThis free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all. \nDURATION: 1 hour \nSpeaker Profiles:  \n\nChaired by: Dr Nicola Wall\, Chief Executive Officer\, Afortiori Development\nNicola co-founded Afortiori Development after a long career in clinical research within a variety of roles.  Nicola has extensive experience and a proven track record in global clinical trial management\, quality assurance and process management in the healthcare industry. Afortiori have built an impressive global team of clinical trial specialists\, clinicians and biostatisticians with experience in adult\, paediatric and neonatal clinical research\, and both primary and secondary healthcare settings. \n \nPeter Bannister\, Managing Director\, Romilly Life Sciences Ltd\nPeter has helped build multiple high-growth biomedical businesses\, commercialising innovative products for surgery\, diagnostics and digital treatment pathways across international markets and leading R&D\, regulated product development and strategic business development.  He founded Romilly Life Sciences to help cross-sector teams from health\, tech and pharma organisations implement\, evidence and scale solutions based on data and artificial intelligence (AI). He is also co-founder of Migration Biotherapeutics\, Honorary Professor at the University of Birmingham Centre for Regulatory Science and Innovation\, Fellow and Chair of Healthcare at the Institution of Engineering and Technology\, an Academy of Medical Sciences Future Leader in Innovation Enterprise and Research (FLIER) and serves as NIHR Industry Spokesperson on AI. \n\nDr Lauris Kemp\, Partner\, HGF Ltd\nLauris is a UK and European patent attorney and a partner in HGF’s biotech team. She has a strong life sciences background with a first degree in Immunology and Biochemistry; and a PhD and 6 years post-doctoral experience covering cell expression systems\, protein purification\, mass spectrometry\, protein crystallography and bioinformatics. Her patent work reflects this broad base and Lauris handles increasing numbers of bioinformatics applications\, securing commercially useful claims for clients. She has drafted and prosecuted bioinformatics applications in metagenomic and microbiome sequencing\, in silico drug testing and AI cancer diagnostics. She has also successfully defended bioinformatics patents at EPO opposition proceedings. \n\nTimothy Bubb\, Technical Director\, IMed Consultancy Ltd\nWith more than ten years’ experience in QA/RA roles\, Tim has breadth and depth of knowledge across the regulatory\, engineering\, clinical\, design and development\, and quality assurance disciplines.  Tim has a passion for empowering innovation in medical devices and brings insight and pragmatism to projects bringing complex lifesaving and life enhancing products to market. \n  \n 
URL:https://staging.medilinkmidlands.com/event/webinar-validating-digital-health-from-artificial-intelligence-to-clinical-evidence/
CATEGORIES:Project Event
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR